Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
OECD: Iran war dampening global growth - 2Conquering Social Generalizations: Individual Accounts of Strengthening
- 3NASA study shows how satellite 'light pollution' hinders space telescopes
- 4This ‘CSI: Miami’ star spent years solving crimes on TV. Then she became the target of one herself.
- 5Impact of NIH funding reductions felt in cancer and infectious disease trials
- NASA releases stunning first images of Earth taken by the Artemis II astronauts
- Step by step instructions to Figure out the Natural Effect of 5G Pinnacles
- How is 'A Knight of the Seven Kingdoms' connected to 'Game of Thrones'?
- Israel's haredi draft crisis: Court ruling and political stalemate reach breaking point
- Vote In favor of Your Favored IT Administration
- How Much Has the Iran War Cost the Average American Per Day?
- Pick Your Favored kind of soup
- Toilet rats? Washington health officials warn of possible rodents in sewer systems after floods
- Step by step instructions to Boost the Eco-friendliness of Your Smash 1500.
